TDOC Q1 2026 Earnings Call Summary | Stock Taper
Logo
TDOC

TDOC — Teladoc Health, Inc.

NYSE


Q1 2026 Earnings Call Summary

April 30, 2026

TDOC Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

  • Consolidated Revenue: $614 million, exceeding guidance midpoint.
  • Adjusted EBITDA: $58 million, representing a 9.5% margin.
  • Net Loss per Share: $0.36, impacted by amortization, stock-based compensation, and restructuring costs.
  • Free Cash Flow: Net outflow of $26 million; cash and cash equivalents at $751 million.
  • Integrated Care Revenue: $395 million, a 1.5% year-over-year increase.
  • BetterHelp Revenue: $218 million, down 9% year-over-year, with a decline in average paying users to 361,000.

2. Strategic Updates and Business Highlights

  • Integrated Care Segment: Focus on scaling services and enhancing offerings, particularly in chronic care and mental health. The shift from subscription to visit-based models is seen as an opportunity for growth.
  • BetterHelp: Successful rollout of insurance coverage, now live in 30 states with over 6,000 credentialed providers. Insurance revenue is projected to reach $125 million by year-end.
  • AI Integration: Investments in AI and data infrastructure to improve service delivery and operational efficiency.
  • Operational Efficiency: Emphasis on cost management and productivity initiatives across both segments.

3. Forward Guidance and Outlook

  • 2026 Revenue Guidance: Expected to be between $2.48 billion and $2.58 billion, with adjusted EBITDA of $267 million to $306 million.
  • Q2 2026 Guidance: Revenue expected between $597 million and $626 million, with adjusted EBITDA between $55 million and $67 million.
  • Integrated Care: Anticipated growth in the second half of 2026, driven by contract implementations and enhanced visit revenue.
  • BetterHelp: Revenue expected to decline between 6.5% and 1% year-over-year, with insurance revenue projected at $90 million to $105 million.

4. Bad News, Challenges, or Points of Concern

  • BetterHelp Performance: Continued pressure on the direct-to-consumer cash pay business, leading to a decline in average paying users and overall revenue.
  • Market Dynamics: The shift from subscription to visit-based models has created near-term revenue headwinds, although it is expected to become a tailwind by the end of 2026.
  • Implementation Delays: Some contract implementations have been pushed to the second half of 2026 due to client-driven timing issues.
  • Competitive Pressures: The chronic care market remains crowded with many point solutions, leading to potential challenges in differentiation.

5. Notable Q&A Insights

  • Integrated Care Growth: Management expressed confidence in returning to growth, citing the shift to visit-based arrangements and new product innovations.
  • BetterHelp Insurance Rollout: The insurance strategy is showing positive results, with higher session engagement among insured users compared to cash pay users.
  • Therapist Capacity: Building therapist capacity remains a challenge, but management is optimistic about scaling the insurance-focused offering.
  • Market Stabilization: Early signs of stabilization in the BetterHelp business were noted, particularly in states where insurance has been implemented for longer periods.
  • CFO Search: The search for a new CFO is ongoing, with a focus on finding a candidate that fits well with the organization and can drive financial performance.

Overall, while Teladoc Health is navigating challenges in its BetterHelp segment and the transition to visit-based revenue models, there are positive indicators of growth and strategic initiatives that could enhance its market position moving forward.